Interface (TILE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
4 Nov, 2025Executive summary
Q3 2025 net sales reached $364.5 million, up 5.9% year-over-year (4.2% currency-neutral), driven by strong demand in healthcare and corporate office markets, and supported by the One Interface strategy and product innovation.
GAAP EPS rose 62.5% to $0.78; adjusted EPS increased 27.1% to $0.61, with net income at $46.1 million, reflecting improved gross margins and manufacturing efficiencies.
Gross profit margin expanded by 233 basis points to 39.4% (adjusted: 39.5%), driven by favorable mix, pricing, and productivity gains.
The company maintains a diversified product portfolio and global presence, with industry-leading sustainability and carbon negative innovations.
Investments in automation, productivity, and innovation continue to yield margin improvement and expanded addressable markets.
Financial highlights
Q3 2025 net sales were $364.5 million, up 5.9% as reported and 4.2% currency-neutral year-over-year; LTM net sales at $1,372 million.
Adjusted gross profit margin expanded by 208 bps to 39.5%; GAAP gross margin at 39.4%, up 233 bps year-over-year.
Adjusted operating income was $54.1 million (up 24.5%); adjusted EBITDA was $66.2 million (18.2% of net sales); net income was $46.1 million.
Adjusted EPS was $0.61 (up 27%); GAAP EPS was $0.78 (up 62.5%).
Net debt reduced to $120.4 million, with a net leverage ratio of 0.6x; cash balance at $187.4 million.
Outlook and guidance
Full-year 2025 guidance raised: net sales expected at $1.375–$1.390 billion, adjusted gross profit margin at 38.5%, adjusted SG&A at $362 million, and capital expenditures at $45 million.
Adjusted effective income tax rate guided at 26%; fully diluted share count at 59.1 million.
Q4 expected to continue steady momentum, with strong backlog and order trends supporting guidance.
Liquidity is expected to be sufficient for the next 12 months, with strong cash flows from operations.
Focus remains on margin expansion, supply chain management, and capital returns.
Latest events from Interface
- Record sales, margin expansion, and strong healthcare/education growth set stage for 2026.TILE
Q4 202524 Feb 2026 - Q2 2024 net sales up 5.2%, margin expansion, and raised outlook on strong order growth.TILE
Q2 20242 Feb 2026 - Q3 2024 delivered 10.7% sales growth, margin expansion, and record net income and EPS.TILE
Q3 202417 Jan 2026 - 2024 saw 4.3% sales growth, margin expansion, and improved leverage, with a strong 2025 outlook.TILE
Q4 202423 Dec 2025 - Proxy covers director elections, say-on-pay, auditor change, and highlights ESG leadership.TILE
Proxy Filing1 Dec 2025 - Votes include board elections, executive pay, and auditor ratification, with online voting options.TILE
Proxy Filing1 Dec 2025 - Q1 sales up 2.6%, Americas strong, guidance raised despite margin and macro headwinds.TILE
Q1 202528 Nov 2025 - Q2 2025 saw strong sales, margin gains, and higher guidance, driven by Americas growth.TILE
Q2 202516 Nov 2025